Published in J Appl Physiol (1985) on September 01, 1992
Humoral control of airway tone. Thorax (1996) 1.02
Reflex regulation of airway sympathetic nerves in guinea-pigs. J Physiol (2006) 0.91
Salt and asthma. BMJ (1993) 0.88
Low voltage vagal nerve stimulation reduces bronchoconstriction in guinea pigs through catecholamine release. Neuromodulation (2012) 0.79
Comparison of the effects of salbutamol and adrenaline on airway smooth muscle contractility in vitro and on bronchial reactivity in vivo. Thorax (1994) 0.79
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med (1997) 8.48
Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet (2000) 5.66
Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet (1988) 4.85
Asthma, wheezing, and school absence in primary schools. Arch Dis Child (1989) 4.57
Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet (2004) 3.89
Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects. Thorax (2001) 3.23
Validity and repeatability of the IUATLD (1984) Bronchial Symptoms Questionnaire: an international comparison. Eur Respir J (1989) 3.12
Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study. Thorax (1987) 3.06
Salbutamol and isoproterenol. A double-blind trial to compare bronchodilator and cardiovascular activity. N Engl J Med (1969) 2.99
Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. BMJ (1993) 2.70
Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet (1990) 2.52
Effect of yoga breathing exercises (pranayama) on airway reactivity in subjects with asthma. Lancet (1990) 2.31
Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med (1995) 2.25
Assessment and management of asthma in an accident and emergency department. Thorax (1985) 2.21
Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ (1996) 2.19
Sudden death in asthma: discussion paper. J R Soc Med (1983) 2.13
Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol (1983) 2.10
What symptoms predict the bronchial response to histamine? Evaluation in a community survey of the bronchial symptoms questionnaire (1984) of the International Union Against Tuberculosis and Lung Disease. Int J Epidemiol (1989) 2.05
Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment. Am J Respir Crit Care Med (1999) 2.02
Bronchoprotective role for endogenous prostaglandin E2. Lancet (1995) 2.01
Response to inhaled histamine and 24 hour sodium excretion. Br Med J (Clin Res Ed) (1986) 2.01
The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med (1984) 1.95
beta-adrenergic agonist resistance in normal human airways. Lancet (1977) 1.91
Estimation and repeatability of the response to inhaled histamine in a community survey. Thorax (1987) 1.85
Management of asthma in schools. Arch Dis Child (1987) 1.81
Clinical experience of lymphangioleiomyomatosis in the UK. Thorax (2000) 1.80
Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects. Thorax (1982) 1.77
Comparison of bronchial reactivity and peak expiratory flow variability measurements for epidemiologic studies. Am Rev Respir Dis (1992) 1.73
Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult population sample. Lancet (1994) 1.71
Randomised placebo controlled trial of beta agonist dose reduction in asthma. Thorax (1999) 1.68
The distribution of peak expiratory flow variability in a population sample. Am Rev Respir Dis (1989) 1.66
How patients use domiciliary oxygen. Br Med J (1978) 1.66
Quantitative assessment of bronchial beta-adrenoceptor blockade in man. Br J Clin Pharmacol (1979) 1.65
Comparison of three techniques of inhalation on the airway response to terbutaline. Thorax (1983) 1.64
Comparison of PD20 with two alternative measures of response to histamine challenge in epidemiological studies. Eur Respir J (1993) 1.61
Hypoglycaemic counter-regulation at normal blood glucose concentrations in patients with well controlled type-2 diabetes. Lancet (2000) 1.61
Dosage and delivery of nebulised beta agonists in hospital. Thorax (1983) 1.59
The effect of adrenaline upon cardiovascular and metabolic functions in man. Clin Sci (Lond) (1985) 1.58
Attitudes and long-term adjustment of patients surviving cardiac arrest. Br Med J (1971) 1.57
Adenosine-induced bronchoconstriction in asthma. Antagonism by inhaled theophylline. Am Rev Respir Dis (1984) 1.52
Step 3 of the asthma guidelines. Thorax (1999) 1.48
Airway and metabolic responsiveness to intravenous salbutamol in asthma: effect of regular inhaled salbutamol. Clin Sci (Lond) (1981) 1.46
Bile salt 3 alpha- and 12 alpha-hydroxysteroid dehydrogenases from Eubacterium lentum and related organisms. Appl Environ Microbiol (1979) 1.44
Thoracic epidural analgesia started after cardiopulmonary bypass. Adrenergic, cardiovascular and respiratory sequelae. Anaesthesia (1997) 1.43
Ineffectiveness of burst suppression therapy in mitigating perioperative cerebrovascular dysfunction. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Anesthesiology (1999) 1.42
Guillain-Barre syndrome associated with Campylobacter infection. Br Med J (Clin Res Ed) (1982) 1.42
Bronchodilator drugs. Pharmacol Ther (1982) 1.39
Increased lithogenicity of bile on fasting in normal subjects. Am J Dig Dis (1977) 1.38
Asthma induced by suggestion: is it due to airway cooling? Am Rev Respir Dis (1984) 1.38
Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax (2001) 1.38
Effect of inhaled prostaglandin E2 on allergen-induced asthma. Am Rev Respir Dis (1993) 1.37
Airway and metabolic resistance to intravenous salbutamol: a study in normal man. Clin Sci (Lond) (1980) 1.33
Survival and disease progression in UK patients with lymphangioleiomyomatosis. Thorax (2004) 1.32
Assessment of bronchial beta blockade after oral bevantolol. Clin Pharmacol Ther (1981) 1.32
Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma. Thorax (1988) 1.32
Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis (1991) 1.30
High-dose inhaled albuterol in severe chronic airflow limitation. Am Rev Respir Dis (1988) 1.30
Assessing change in airway calibre--measurement of airway resistance. Br J Clin Pharmacol (1979) 1.29
NAD-dependent 3alpha- and 12alpha-hydroxysteroid dehydrogenase activities from Eubacterium lentum ATCC no. 25559. Biochim Biophys Acta (1977) 1.27
A comparison of the Yan and a dosimeter method for methacholine challenge in experienced and inexperienced subjects. Eur Respir J (1991) 1.26
Measurement of bronchial reactivity: a question of interpretation. Thorax (1981) 1.25
Left ventricular pressures in two patients with myocardial infarction. Lancet (1968) 1.24
Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study. BMJ (1997) 1.20
Effects of beta-adrenergic blockade and stimulation on normal human airways. J Appl Physiol (1973) 1.19
Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects. Thorax (2003) 1.19
Factors influencing the occurrence of airway hyperreactivity in the general population: the importance of atopy and airway calibre. Eur Respir J (1994) 1.17
Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study. Thorax (2006) 1.15
Inhaled frusemide and exercise induced asthma: evidence of a role for inhibitory prostanoids. Thorax (1992) 1.14
Increased whole body protein breakdown predominates over increased whole body protein synthesis in multiple organ failure. Clin Sci (Lond) (1993) 1.14
Asthma control during and after cessation of regular beta 2-agonist treatment. Am Rev Respir Dis (1993) 1.13
Experience with a trigger tool for identifying adverse drug events among older adults in ambulatory primary care. Qual Saf Health Care (2009) 1.10
Reduced respiratory responses to carbon dioxide after propranolol: a central action. Br Med J (1976) 1.09
Age effects on executive ability. Neuropsychology (2000) 1.08
Coeliac disease and HLA-DQ 2 (DQA1* 0501 and DQB1* 0201) in patients with Turner syndrome. J Pediatr Gastroenterol Nutr (2001) 1.08
Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects. Thorax (2000) 1.06
Effects of physiological hypercortisolemia on the regulation of lipolysis in subcutaneous adipose tissue. J Clin Endocrinol Metab (1998) 1.06
Hypoglycaemia, hypothermia and shivering in man. Clin Sci (Lond) (1981) 1.06
Bronchial and cardiac beta-adrenoceptor blockade--a comparison of atenolol, acebutolol and labetalol. Br J Clin Pharmacol (1981) 1.06
Comparison of histamine and methacholine for use in bronchial challenge tests in community studies. Thorax (1988) 1.05
Morbidity from asthma in relation to regular treatment: a community based study. Thorax (1999) 1.05
Effect of beta-adrenergic blockade on respiratory and metabolic responses to exercise. J Appl Physiol Respir Environ Exerc Physiol (1981) 1.04
A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects. Am Rev Respir Dis (1991) 1.04
Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects. Thorax (1997) 1.03
Asthma quality of life during 1 year of treatment with budesonide with or without formoterol. Eur Respir J (1999) 1.03
Adenosine monophosphate and histamine induced bronchoconstriction: repeatability and protection by terbutaline. Thorax (1997) 1.02
Relation of pulmonary lymphangio-leiomyomatosis to use of the oral contraceptive pill and fertility in the UK: a national case control study. Thorax (1994) 1.01
Effect of inhaled prostaglandin E2 on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma. Thorax (1991) 1.01
Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women. J Endocrinol Invest (2009) 1.00
Bile induction of 7 alpha- and 7 beta-hydroxysteroid dehydrogenases in Clostridium absonum. Biochim Biophys Acta (1981) 0.99
Chest x-ray film in acute myocardial infarction. Br Med J (1969) 0.99
Effects of meal composition on the postprandial blood pressure, catecholamine and insulin changes in elderly subjects. Clin Sci (Lond) (1989) 0.97
Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge. Am J Respir Crit Care Med (1994) 0.97
Central nervous system manifestations of hyperparathyroidism. Am J Med (1978) 0.97
Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide. Thorax (2004) 0.97
Effect of ICI 118551 on bronchial beta-adrenoceptor function and exercise heart rate in normal man. Br J Clin Pharmacol (1983) 0.96